Persephone Biosciences logo

Persephone Biosciences

Emerging

Persephone Biosciences uses gut microbiome profiling and synthetic biology to develop cancer immunotherapy response predictors and novel therapeutics; founded 2017 in San Diego; received BARDA funding for microbiome-based diagnostics;

Best for: Microbiome Diagnostics & Oncology TherapeuticsEmerging, rapid growth
34
AI Score
Grade D
AI Visibility Score (Beta)
Life Sciences & BioTechMicrobiome Diagnostics & Oncology TherapeuticsWebsiteUpdated October 2026

Company Overview

About Persephone Biosciences

Persephone Biosciences is a biotechnology company founded in 2017 by Stephanie Culler and Chris Calvert and based in San Diego, California. The company focuses on decoding the human gut microbiome to develop diagnostics and therapeutics in oncology and neonatal health. Its core thesis is that the composition of a patient's microbiome significantly affects how they respond to cancer immunotherapies such as checkpoint inhibitors — a hypothesis supported by a growing body of peer-reviewed clinical research. Persephone's diagnostic platform aims to predict immunotherapy response from a patient's microbiome signature prior to treatment initiation.

Business Model & Competitive Advantage

The company's therapeutic pipeline leverages synthetic biology to engineer microbial communities and metabolites that can modulate immune response in cancer patients. In parallel, Persephone has pursued microbiome-based interventions for infant health, including programs targeting necrotizing enterocolitis (NEC), a severe gastrointestinal condition in preterm infants. The company received funding from the Biomedical Advanced Research and Development Authority (BARDA), a US government agency, for its microbiome diagnostics work — providing both capital validation and a regulatory pathway anchor.

Competitive Landscape 2025–2026

Persephone Biosciences competes in the emerging microbiome medicine space alongside companies like Seres Therapeutics and Vedanta Biosciences but occupies a distinct niche through its dual focus on oncology companion diagnostics and infant health. The company has pursued collaborations with major cancer centers to validate its predictive platform in clinical settings. As microbiome science matures and companion diagnostics gain regulatory traction, Persephone's combined diagnostics-plus-therapeutics strategy could prove to be a meaningful differentiator in the oncology precision medicine market.

Founded
2017
Headquarters
San Diego, California
Curated content • Fact-checked and verified

Key Differentiators

Emerging Innovator

Persephone Biosciences is an emerging player bringing innovative solutions to the Life Sciences & BioTech market.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

34
→ Stable

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Emulate logo

Emulate

Life Sciences & BioTech
HealthtechB2bEnterpriseAi PoweredHardwarePlatformStartupScaleupGlobalNorth America

Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m

Tempus logo

Tempus

Life Sciences & BioTech
HealthtechB2bAi PoweredAnalyticsPlatformPublicSaasTechnologyNorth America

Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o

Karius logo

Karius

Life Sciences & BioTech
HealthtechAi PoweredB2bEnterpriseNorth AmericaTechnologyAnalytics

Karius is a Redwood City, CA-based life sciences company founded in 2014 that developed the Karius Test — a single blood draw that uses next-generation sequencing and AI to detect over 1,000 pathogens

ConcertAI logo

ConcertAI

Life Sciences & BioTech
HealthtechAi PoweredAnalyticsB2bSaasEnterpriseData WarehousePlatformUnicorn

ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult

Neuralink logo

Neuralink

Life Sciences & BioTech
HealthtechHardwareAi PoweredB2b2cStartupDecacornNorth AmericaTechnologyPlatformEnterprise

Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa

DNAnexus logo

DNAnexus

Life Sciences & BioTech
B2bSaasHealthtechCloud NativeAnalyticsEnterprisePlatformGlobalAi PoweredInfrastructure

DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a

For Persephone Biosciences

Claim This Profile

Are you from Persephone Biosciences? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Persephone Biosciences Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Persephone Biosciences vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →